Evidence map›Paper›PMID 35462437›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2022

Non-invasive transcriptomic analysis using mRNAs in skin surface lipids obtained from children with mild-to-moderate atopic dermatitis.

K Shima, T Inoue, Y Uehara, M Iwamura, S Fukagawa, T Kuwano, K Tanida, N Takada, M Saito-Abe, K Yamamoto-Hanada and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Skin microbiota: pathogenic roles and implications in atopic dermatitis.Frontiers in cellular and infection microbiology · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

K ShimaBiological Science Research, Kao Corporation, Tochigi, Japan.ORCID https://orcid.org/0000-0002-9989-5400
T InoueBiological Science Research, Kao Corporation, Tochigi, Japan.ORCID https://orcid.org/0000-0003-1038-4127
Y UeharaBiological Science Research, Kao Corporation, Tochigi, Japan.ORCID https://orcid.org/0000-0001-7329-4837
M IwamuraBiological Science Research, Kao Corporation, Tochigi, Japan.
S FukagawaBiological Science Research, Kao Corporation, Tochigi, Japan.ORCID https://orcid.org/0000-0001-8491-7868
T KuwanoBiological Science Research, Kao Corporation, Tochigi, Japan.ORCID https://orcid.org/0000-0001-8267-1868
K TanidaBiological Science Research, Kao Corporation, Tochigi, Japan.
N TakadaBiological Science Research, Kao Corporation, Tochigi, Japan.
M Saito-AbeAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
K Yamamoto-HanadaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Y OhyaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
T MuraseBiological Science Research, Kao Corporation, Tochigi, Japan.ORCID https://orcid.org/0000-0002-5496-0133
Kao Corporation (Japan) · JPNational Center For Child Health and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpecimens for analysing the molecular pathology of skin disease are generally obtained through invasive methods, such as biopsy. However, less burdensome methods are desirable for paediatric patients. We recently established a method that comprehensively analyses RNA present in sebum (skin surface lipid-RNAs: SSL-RNAs) using a next-generation sequencer. Using this method, biological information can be obtained from the skin in a completely non-invasive manner.

objectivesTo verify the applicability of the SSL-RNA method for analysis of paediatric skin and analyse the molecular pathology of mild-to-moderate atopic dermatitis (AD) in children.

methodsWe collected sebum specimens from the whole faces of 23 healthy children and 16 children with mild-to-moderate AD (eczema area and severity index (EASI) score: 5.9 ± 2.6) ranging in age from 6 months to 5 years, using an oil-blotting film. We then extracted SSL-RNAs from the samples and performed an AmpliSeq transcriptomic analysis.

resultsThe expressions of genes related to keratinization (LCE, PSORS1C2, IVL and KRT17), triglyceride synthesis and storage (PLIN2, DGAT2 and CIDEA), wax synthesis (FAR2), ceramide synthesis (GBA2, SMPD3 and SPTLC3), antimicrobial peptides (DEFB1) and intercellular adhesion (CDSN), all of which are related to the skin barrier, are lower in children with AD than in healthy children. The children with AD also have higher expression of CCL17, a Th2-cytokine and an increased Th2-immune response as demonstrated by a gene set variation analysis. Moreover, KRT17 and CCL17 expression levels are significantly correlated with the EASI score.

conclusionsMolecular changes associated with abnormal immune responses and the epidermal barrier in children with mild-to-moderate AD can be determined using the SSL-RNA method. This non-invasive method could therefore be a useful means for understanding the molecular pathology of paediatric AD.

Indexed as

beta-DefensinsDermatitis, AtopicChildGene Expression ProfilingHumansIntercellular Signaling Peptides and ProteinsLipidsRNA, MessengerSeverity of Illness IndexTranscriptomebeta-DefensinsCDSN protein, humanDEFB1 protein, humanIntercellular Signaling Peptides and ProteinsLipidsRNA, Messenger

Identifiers

PMID35462437
PMCPMC9545805
OpenAlexW4224317172

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.